Clinical trial
Randomized Study on Neoadjuvant Radio-Chemotherapy in Rectal Carcinoma Dukes B…
NCT00309517 · Austrian Breast & Colorectal Cancer Study Group, Other · Terminated
Key facts
| NCT number | NCT00309517 |
|---|---|
| Title | Randomized Study on Neoadjuvant Radio-Chemotherapy in Rectal Carcinoma Dukes B and C |
| Official title | A Prospectively Randomized Study on Neoadjuvant Radio-Chemotherapy in Patients With Operated Rectal Carcinoma Dukes B and C (pT2, pN1-3; pT3-4, pN0-3; M0. |
| Lead sponsor | Austrian Breast & Colorectal Cancer Study Group, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rectal Cancer Dukes B, Dukes C |
| Intervention type | Drug |
| Interventions | Fluourouracil, Leucovorin, MAb 17-1A |
| Enrollment | 700 |
| Start date | Jul 1, 1997 |
| First posted | Apr 3, 2006 |
| Last update posted | Apr 3, 2006 |
| Countries | Austria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: